These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25012779)
1. Letter to the editor: reply to Legare et al. van Westrhenen R; Schulte PF; Sommer I Med Hypotheses; 2014 Sep; 83(3):418. PubMed ID: 25012779 [No Abstract] [Full Text] [Related]
2. Dosing strategies of clozapine-fluvoxamine cotreatment. Lu ML; Lane HY; Jann MW; Chang WH J Clin Psychopharmacol; 2002 Dec; 22(6):626-8. PubMed ID: 12454566 [No Abstract] [Full Text] [Related]
4. Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy. Légaré N; Grégoire CA; De Benedictis L; Dumais A Med Hypotheses; 2013 Jun; 80(6):689-91. PubMed ID: 23490199 [TBL] [Abstract][Full Text] [Related]
5. Adjunctive fluvoxamine with clozapine. Lu ML; Lane HY Br J Psychiatry; 2003 Jan; 182():81. PubMed ID: 12509328 [No Abstract] [Full Text] [Related]
6. [Addition of fluvoxamine to clozapine: theory and practice]. Wigard ME; van Gool AR; Schulte PF Tijdschr Psychiatr; 2013; 55(2):113-21. PubMed ID: 23408363 [TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine augmentation for clozapine-resistant schizophrenia. Silver H; Kaplan A; Jahjah N Am J Psychiatry; 1995 Jul; 152(7):1098. PubMed ID: 7793452 [No Abstract] [Full Text] [Related]
8. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on. Gahr M; Rehbaum K; Connemann BJ Pharmacopsychiatry; 2014 May; 47(3):118-20. PubMed ID: 24846087 [TBL] [Abstract][Full Text] [Related]
11. Coadministration of clozapine and fluvoxamine in psychotic patients--clinical experience. Lammers CH; Deuschle M; Weigmann H; Härtter S; Hiemke C; Heese C; Heuser I Pharmacopsychiatry; 1999 Mar; 32(2):76-7. PubMed ID: 10333167 [TBL] [Abstract][Full Text] [Related]
12. The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review. Polcwiartek C; Nielsen J Psychopharmacology (Berl); 2016 Mar; 233(5):741-50. PubMed ID: 26626327 [TBL] [Abstract][Full Text] [Related]
13. Plasma clozapine concentration coefficients of variation in a long-term study. Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958 [TBL] [Abstract][Full Text] [Related]
14. Response to Thornton et al. Rajji TK Am J Psychiatry; 2015 Dec; 172(12):1259-60. PubMed ID: 26619774 [No Abstract] [Full Text] [Related]
15. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations. Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974 [TBL] [Abstract][Full Text] [Related]
17. A Case of Mutism in Noncatatonic Schizophrenia Responding to Small Dose of Fluvoxamine Addition to Clozapine. Hirakawa H; Terao T; Tanaka T; Sato H; Yoshimura R J Clin Psychopharmacol; 2016 Oct; 36(5):531-2. PubMed ID: 27508430 [No Abstract] [Full Text] [Related]
18. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. Rajji TK; Mulsant BH; Davies S; Kalache SM; Tsoutsoulas C; Pollock BG; Remington G Am J Psychiatry; 2015 Jun; 172(6):579-85. PubMed ID: 25859763 [TBL] [Abstract][Full Text] [Related]